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  A b s t r a c t
   Background/Aims:  The aim of this study was to investigate onset patterns and initial symptoms 
in patients with dementia with Lewy bodies (DLB) and their association with SPECT findings. 
  Methods:  We studied 29 probable and 12 possible DLB patients. Onset was defined as ‘acute’ 
when symptoms (in various combinations) present within a few weeks or ‘chronic’ when a few 
symptoms present and progress during a longer period of time. Initial symptoms were dichoto-
mized into ‘cognitive’ and ‘non-cognitive’. We conducted voxel-to-voxel statistical analyses of 
SPECT, and uptake deviations from age-matched controls were depicted with Z-scores.  Results:  
In acute patients, decreases were more apparent in the bilateral frontal and temporal lobes, 
whereas chronic patients showed decreases in the bilateral occipital, posterior cingulate and 
precuneal regions. Differences in the left frontal and left posterior cingulate were significant 
and those in the left temporal region showed a tendency toward significance. Patients with 
cognitive symptoms demonstrated more marked decreases in the bilateral temporal, parietal, 
occipital, cingulate and precuneal regions. Differences in the left parietal area reached signifi-
cance and the total decreases were larger in patients with cognitive than non-cognitive symp-
toms, with a trend toward significance.   Conclusions:  The multiplicity of onset patterns and ini-
tial symptoms may possibly be based on pathophysiological diversities in DLB.
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  Introduction
    In patients suffering from dementia with Lewy bodies (DLB), diagnostic precision has 
increased owing to more extensive use of the consensus diagnostic criteria  [1]  as well as surg-
ing awareness of this newcomer among the physicians. However, DLB is still one of the most 
under- or misdiagnosed dementias resulting in rather low sensitivity of the diagnostic crite-
ria for DLB (22–83%) in contrast with a much higher specificity (79–100%)   [2, 3]  . Possible 
reasons for the difficulties in reaching a correct diagnosis of DLB may include a diversity of 
onset patterns and initial symptoms. Onset and progression are typically gradual and chron-
ic, as suggested by the consensus criteria. In contrast, some DLB patients show multiple acute 
symptoms in various combinations and reach rather high levels of disability in a short time 
period. These DLB patients may pose diagnostic difficulty and are most likely misdiagnosed.
    A related issue that may complicate the initial diagnosis of DLB may be the multiplicity 
of the presenting symptoms, ranging from only one symptom of cognitive, psychiatric, mo-
toric or autonomic impairment to various symptom combinations. For instance, amnesia, 
appetite loss and fainting, although common in DLB, may appear mutually unrelated so that 
their combination hardly suggests DLB as a possible first-choice diagnosis.
    Another pitfall in DLB diagnosis is the misinterpretation of one of the supportive fea-
tures included in the diagnostic criteria, namely ‘generalized low uptake   with reduced oc-
cipital activity  ’ on functional imaging   [1]  . In extreme cases, typical DLB patients without 
apparent uptake decreases in the occipital regions tend to be branded as ‘DLB unlikely’ only 
because of negative SPECT findings. It should be kept in mind that low uptake in the oc-
cipital areas is a feature distinguishing DLB from Alzheimer’s disease (AD)   [4–11]  , and that 
it is not a ubiquitous finding among patients with DLB   [9, 12, 13]  . Compared with normal 
controls, DLB patients may rather show lowered uptake in the frontal, parietal, temporal and 
thalamic regions   [14]  . Thus, ‘occipital uptake decreases on SPECT’ is not the gold standard 
for the diagnosis of DLB, and blind dependence on this supportive diagnostic feature may be 
misleading.
    Because DLB shares a common pathological etiology with AD and Parkinson’s disease 
(PD), it is understandable that the majority of functional imaging studies in DLB have tar-
geted at the differential diagnosis of DLB from AD   [4–12]   or PD   [14–16]  . In contrast, only a 
minority of studies have focused upon the association between SPECT findings and specific 
functional impairments in DLB patients, namely motor symptoms   [7, 17]  , visual hallucina-
tion   [18]   or cognitive decline   [14, 19]  . Previously published studies suggested a link between 
hypoperfusion at the bilateral parietal   [20, 21]   or left temporal   [20]   regions and overall cog-
nitive impairment in PD with dementia (PDD). Specifically, left parietal hypoperfusion was 
suggested to be associated with low Mini Mental State Examination (MMSE) scores  [20] , and 
hypoperfusion at the precuneus and inferior parietal regions with impairment in visuospa-
tial maneuvers and perception   [11, 19]   in patients with DLB and PDD.
    So far, SPECT uptake patterns in association with onset types (acute and chronic) and 
initial symptoms (cognitive and non-cognitive) of DLB have not yet been investigated. Thus, 
brain regions and pathophysiological features that may relate to these clinical diversities are 
unknown. We conducted this study firstly to summarize onset patterns and initial symp-
toms of DLB patients, secondly to correlate these clinical varieties with quantitative SPECT 
analyses, and thirdly to try to elucidate, although preliminarily, possible responsible patho-
physiological features. Understanding their relationships may help to broaden our knowl-
edge on DLB and strengthen the diagnostic power of the current criteria, especially in atyp-
ical cases.239
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  Patients  and  Methods
  P a t i e n t s
    We recruited 54 consecutive patients who satisfied the consensus criteria for DLB in the 
period from 2005 to 2010. We further confirmed the diagnosis of DLB at the time of the pres-
ent study on the basis of clinical courses after the first presentation. All 54 patients under-
went brain MRI,   99m Tc ethylcysteinate dimer (ECD) SPECT and   123 I-meta-iodobenzylguani-
dine (MIBG) myocardial scintigraphy as diagnostic procedures. Then, in the secondary 
analyses, we included only those who showed abnormalities on MIBG myocardial scintigra-
phy that are considered suggestive of DLB: heart/mediastinum (H/M) uptake ratio   !  1.68 
and/or washout rate   1  23.6%   [22]  . We adopted these rather stringent inclusion criteria in or-
der to compensate for a lack of pathological confirmation. Brain MRI was used to exclude 
patients with apparent vascular lesions ( 1  3 mm), idiopathic normal pressure hydrocephalus, 
subdural hematoma or brain tumor. Patients with a past/present history of alcoholism, drug 
abuse, brain trauma or debilitating diseases were excluded. Thirteen patients did not satisfy 
some of these requirements and were therefore excluded from the study, and 41 (29 probable 
and 12 possible) DLB patients were finally included in the investigation. This study was ap-
proved by the Ethics Committee of the Showa University Northern Yokohama Hospital.
    Definition of Onset Patterns and Initial Symptoms
    Clinical history data were obtained from reliable kin. Onset type was defined as ‘acute’ 
when cognitive, psychiatric, motoric or autonomic symptoms, frequently in various combi-
nations, appeared in a rush in patients who had not shown any previous neurological or cog-
nitive deficits and made them highly disabled within a few days or up to a few weeks. In 
contrast, onset was defined as ‘chronic’ when either a single or a couple of symptoms occur-
ring one after another gradually progressed within a period of 6 months or more. Because 
patients were diagnosed with DLB according to the criteria, progressive cognitive decline 
(central feature) was noted during the follow-up period even when patients initially present-
ed physical/autonomic symptoms. We did not include patients who showed a clinical course 
typical of PD for years before developing cognitive impairment (PDD). 
    We classified initial symptoms as cardinal and auxiliary: among multiple symptoms at 
presentation, the earliest and most prominent ones were designated as cardinal and those of 
lesser importance or severity as auxiliary. Cardinal initial symptoms were further dichoto-
mized into ‘cognitive’ (cognitive and/or psychiatric) and ‘non-cognitive’ (motoric and/or au-
tonomic). The rationale behind this classification is that cognitive and psychiatric, or physi-
cal and autonomic symptoms are often difficult to be delineated from each other. By and 
large, memory, visuospatial and executive impairments, and somnolence and cognitive fluc-
tuations were classified as cognitive; hallucinations, delusions, misidentification syndrome, 
phantom boarders, mood and character changes and REM sleep behavioral disorder as psy-
chiatric; parkinsonian symptoms represented by gait disturbance, easy falling, bradykinesia, 
rigidity and tremor as motoric, and loss of appetite, orthostatic hypotension, fainting and 
restless leg syndrome as autonomic. ‘Ensuing’ symptoms are those in favor of the diagnosis 
of DLB that appeared later during the follow-up period after the initial evaluation.
  Voxel-Based  SPECT  Analyses
    We analyzed the results of   99m Tc-ECD SPECT using two related voxel-based statistical 
programs, namely the Easy Z-score Imaging System (eZIS)   [23]   and the voxel-based Stereo-
tactic Extraction Estimation Program (vbSEE)  [24] . The eZIS program processes the original 
SPECT data so that the brain morphology is anatomically remodeled and brain areas were 
defined according to Talairach and Tournoux normal brain. Then, voxel-by-voxel uptake 240
Dement Geriatr Cogn Disord Extra 2011;1:237–248
 DOI:  10.1159/000330345 
EXTRA
  Fukui et al.: Onset Patterns, Initial Symptoms and Related SPECT Findings in DLB 
www.karger.com/dee
    © 2011 S. Karger AG, Basel
  Published online: August 5, 2011 
changes were compared with data obtained from 283 normal age-matched controls and 
shown qualitatively by a spectrum of colors on the morphologically normalized brain   [23]  . 
In the next step, we used the vbSEE program to quantify SPECT data that had been processed 
by the eZIS program as described. Specifically, the vbSEE program calculated the percentage 
of voxels that showed uptake decreases of 2 standard deviations or more from the average of 
age-matched normal controls (designated as extension) in a specific brain area, and the aver-
age of Z-scores of these voxels (severity). Then we used their products (extension  !   severity) 
as the indices of uptake reduction representing the frontal, temporal, parietal and occipital 
lobes, anterior and posterior cingulate, and precuneus, as defined according to the Talairach 
coordinate system. 
  S t a t i s t i c s
  We used SPSS version 17.0J for statistical analyses. As Z-scores are defined to have a nor-
mal distribution, we used Student’s t test to compare local Z-scores and a logistic regression 
to seek the loci of hypoperfusion that are the most relevant to onset patterns (acute or chron-
ic) or initial symptoms (cognitive or non-cognitive). A p value   !  0.05 represented statistical 
significance.
  R e s u l t s
    Patient Demography and MIBG Myocardial Scintigraphy
    Patient demography and results of MIBG myocardial scintigraphy are summarized in 
  table 1  . Age and gender distribution were comparable between the groups defined by either 
onset types or initial symptoms. Duration of illness, defined as the time span (months) be-
tween the emergence of the first symptoms and presentation to the hospital, was significant-
ly shorter for the acute- than chronic-onset group. The cognitive group showed a longer du-
ration, although non-significantly, than the non-cognitive group.
    The indices of MIBG myocardial scintigraphy (H/M ratios and washout ratios) did not 
differ between patient groups with different onset patterns. In the non-cognitive group, late 
H/M ratios were significantly smaller and the washout ratios were larger with a tendency 
toward significance compared with the cognitive group. Early H/M ratios were also lower in 
the non-cognitive group, although non-significantly. More apparent abnormalities on MIBG 
myocardial scintigraphy in the non-cognitive group may be reflective of inclusion of auto-
nomic patients in this group.
    Onset Patterns and Initial Symptoms
      Table 2   shows the diagnoses (probable vs. possible), onset patterns (acute vs. chronic), 
types of initial symptoms (cognitive and non-cognitive) and their details (cardinal vs. auxil-
  Table  1.    Patient demography and the results of MIBG myocardial scintigraphy
Age
years
p Males
%
p Duration 
months
p  Early H/M p  Late H/M p  Washout 
rates
p 
Acute onset (n = 21) 77.5  8  10.7 0.64 43 0.65 2.2  8  1.8 0.0005 1.69  8  0.36 0.22 1.61  8  0.43 0.34 40.3  8  9.7 0.80 Chronic onset (n = 20) 76.3  8  5.1 50 21.0  8  9.4 1.57  8  0.27 1.50  8  0.33 41.0  8  8.7
Cognitive (n = 31) 76.3  8  9.0 0.26 45 0.79 13.0  8  12.2 0.14  1.67  8  0.33 0.33 1.62  8  0.40 0.01 38.6  8  9.3 0.09 Non-cognitive (n = 10) 79.5  8  5.3 50 6.3  8  7.6 1.53  8  0.25 1.33  8  0.21 46.7  8  5.5
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Age
years
Gender Dura-
tion
months
HDSR Diag-
nosis
Onset Initial 
Sx
I  nitial symptoms Ensuing symptoms
cardinal auxiliary
78  M 1 ND Prob. A Cog. hallucinations orthostatic hypotension, gait 
disturbance, apathy
70  F 1 24 Prob. A Cog. apathy, delusion appetite loss, gait 
disturbance
57 F 2 ND Prob. A Cog. incoherence,  cognitive 
fluctuations
disturbed 
consciousness, 
appetite loss
72 F 0.5 ND Prob. A Cog. depression, 
hallucinations, irritability
parkinsonism
88 F 3 22 Prob. A Cog. amnesia,  executive 
dysfunction
parkinsonism, apathy, cognitive 
fluctuations
82 M 2 7 Prob. A Cog. amnesia, somnolence, 
hallucinations, 
misidentification
parkinsonism
82 M 2 ND Prob. A Cog. hallucinations, dyscalculia, 
executive dysfunction
cognitive fluctuations, sudden 
akinesia
55 M 4 9 Prob. A Cog. amnesia, hallucinations, 
disinhibition, cognitive 
fluctuations
56 F 2 ND Prob. A Cog. hallucinations aberrant  behaviors
79 M 6 18 Prob. A Cog. somnolence,  cognitive 
fluctuations
appetite loss, gait 
disturbance
parkinsonism
84 F 1 22 Prob. A Cog. hallucinations parkinsonism,  apathy
69 M 0.5 23 Prob. A Cog. hallucinations appetite loss, gait disturbance, 
tremor
90 F 6 10 Poss. A Cog. amnesia, hallucinations, 
disorientation
93 M 1 13 Poss. A Cog. hallucinations
78  M 2 17 Prob. A N-Cog. appetite loss, restless leg 
syndrome
hallucinations, REM sleep 
behavioral disorder
87  F 3 27 Prob. A N-Cog. appetite loss parkinsonism amnesia, hallucinations, drug 
sensitivity
81  F 1 11 Prob. A N-Cog. gait disturbance amnesia, cognitive fluctuations
85 F 1 4 Prob. A N-Cog. gait disturbance amnesia, hallucinations, 
disorientation
79 F 1 ND Poss. A N-Cog. syncope parkinsonism,  apathy
80 F 6 9 Poss. A N-Cog. gait disturbance misidentification of people
73 M 1 ND Poss. A N-Cog. syncope parkinsonism
69  M 24 17 Prob. C Cog. bradyphrenia parkinsonism cognitive decline, hallucinations, 
delusions
74  M 12 23 Prob. C Cog. hallucinations, delusions cognitive decline, parkinsonism
67 F 24 25 Prob. C Cog. hallucinations,  visual 
illusion
74  F 24 17 Prob. C Cog. amnesia parkinsonism delusion of theft, misidentification 
of people
69  F 12 21 Prob. C Cog. somnolence hallucinations, delusions, gait 
disturbance
  Table  2.    Initial and ensuing symptoms242
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iary), ensuing symptoms, duration of illness and the scores of the revised Hasegawa Dementia 
Scale (HDSR) at the first evaluation, a short cognitive test similar to the MMSE with a total 
score of 30. We could not administer the HDSR to some patients because of fluctuating men-
tal clarity. The average HDSR scores did not differ between acute (mean   8   SD: 15.4   8   7.3) 
and chronic (17.5   8   7.2) groups (p = 0.44; Mann-Whitney U test), or cognitive (16.6   8   6.9) 
and non-cognitive (16.4   8   8.8) groups (p = 0.96), indicating that global cognition was ubiq-
uitously impaired at the time of evaluation regardless of onset patterns and initial symptoms.
      Table 3   shows the frequencies of initial and ensuing symptoms of acute or chronic, and 
cognitive or non-cognitive patients. The frequency of symptoms was defined as the percent-
age of each symptom among those grouped as either cardinal, auxiliary or ensuing. In cog-
nitive groups, hallucinations (33%), executive impairment (15%), somnolence (15%), amnesia 
(13%) and cognitive fluctuations (13%) constituted the most frequent symptoms in the acute-
onset patients, whereas amnesia (41%) was the most common together with hallucinations 
(17%) and delusions (10%) in chronic-onset patients. For auxiliary symptoms in the cognitive 
groups, parkinsonism and appetite loss were prevalent in acute-onset patients. All patients 
with eating problems underwent meticulous gastrointestinal investigations that revealed no 
organic abnormalities. Appetite loss did not represent negativism toward eating and thus was 
Age
years
Gender Dura-
tion
months
HDSR Diag-
nosis
Onset Initial 
Sx
I  nitial symptoms Ensuing symptoms
cardinal auxiliary
78  F 24 22 Prob. C Cog. amnesia, depression gait disturbance
72 M 12 14 Prob. C Cog. apathy hallucinations, parkinsonism
82 F 36 11 Prob. C Cog. amnesia hallucinations, cognitive 
fluctuations, parkinsonism
78 M 36 14 Prob. C Cog. amnesia misidentification  syndrome, 
gait disturbance
83 M 12 13 Prob. C Cog. amnesia, hallucinations, 
delusions, irritability
79 F 12 22 Poss. C Cog. amnesia
72 M 36 4 Poss. C Cog. amnesia parkinsonism
80 F 24 ND Poss. C Cog. amnesia, hallucinations, 
delusions
77  F 12 16 Poss. C Cog. amnesia cognitive fluctuations, gait 
disturbance
79 M 36 21 Poss. C Cog. amnesia
82 F 12 1 Poss. C Cog. amnesia, inattention hallucinations, visual illusion
79 F 24 27 Poss. C Cog. amnesia, executive 
dysfunction, personality 
change
parkinsonism
69  M 12 26 Prob. C N-Cog. parkinsonism depression, hallucinations, delusions
81 M 24 ND Prob. C N-Cog. hypotension cognitive 
fluctuations
amnesia, apathy, parkinsonism
81 M 12 21 Prob. C N-Cog. gait disturbance amnesia, hallucinations
  Pa  tient backgrounds, diagnoses, onset patterns [acute (A) and chronic (C)], classification based on the initial symptoms (Sx): [cognitive/psy-
chiatric (Cog.) and motoric/autonomic (N-Cog.)] and contents of the initial and ensuing symptoms in all 41 patients are shown. ND = Not done; 
Poss. = possible; Prob. = probable. 
 
 
  Table  2   (continued) 243
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interpreted as a sign of autonomic dysfunction. In chronic-onset cognitive patients, parkin-
sonism and cognitive fluctuations were most likely to accompany the cardinal cognitive/
psychiatric symptoms.
  In the non-cognitive group, parkinsonism was the most frequent symptom regardless of 
the onset types. Autonomic disturbances were various (appetite loss, orthostatic hypoten-
sion/syncope and restless leg syndrome) and more frequent in acute- than chronic-onset pa-
tients, in whom orthostatic hypotension/syncope was the only autonomic impairment. In 
both onset types, amnesia (25%) and hallucinations (25%) may be later added to the initial 
clinical pictures. Non-cognitive patients with acute onset may further experience disorienta-
tion, cognitive fluctuation, misidentification syndrome and apathy (6% for each). In contrast, 
compared with patients with acute onset, patients with chronic onset may more often (13%) 
develop psychiatric problems such as delusions, apathy and depression.
  Quantitative  SPECT  Analyses
      Figure 1   shows uptake reductions, expressed by ‘extension   !   severity’ calculated by the 
vbSEE program for each brain area under consideration in all 41 DLB patients regardless of 
the onset patterns and initial symptoms. Given DLB patients were compared with age-matched 
normal controls, DLB patients demonstrated rather diffuse uptake decreases that were not 
necessarily restricted to the occipital areas. Contrarily, uptake decreases appeared rather 
milder in the occipital than in the frontal, parietal, anterior cingulate or precuneal regions. 
   Acute versus Chronic Onset . The acute-onset group (cognitive and non-cognitive groups 
combined) showed more pronounced uptake decreases in bilateral frontal and temporal 
  Table  3.    Contents and frequency of cognitive, psychiatric, motoric and autonomic symptoms
Symptoms Acute cognitive Chronic cognitive Acute non-cognitive C  hronic non-cognitive
cardinal auxiliary ensuing cardinal auxiliary ensuing cardinal auxiliary ensuing cardinal auxiliary ensuing
 Cognitive 
Amnesia 13% 41% 25% 25%
Executive impairment 15% 9%
Dyscalculia 3%
Disorientation 3% 6%
Somnolence 15% 3%
Cognitive fluctuation 13% 14% 19% 6% 25% 9% 6% 100%
 Psychiatric 
Hallucinations 33% 17% 26% 25% 25%
Delusions 3% 10% 13% 13%
Misidentification 3% 9% 6%
Incoherence 3%
Apathy 3% 19% 6% 13%
Depression 3% 3% 13%
Irritability 3% 3%
Disinhibition 3%
Character changes 3%
Aberrant behaviors 6%
REM sleep behavioral disorder 6%
 Motoric 
Parkinsonism 43% 31% 75% 35% 44% 13% 12% 67% 13%
 Autonomic 
Appetite loss  43% 6% 22%
Othostatic hypotension/syncope 6% 22% 33%
Restless leg syndrome  11%
Drug hypersensitivity 6%
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lobes whereas the chronic group showed reductions of a higher degree in the bilateral oc-
cipital, posterior cingulate and precuneal regions ( fig. 2 ). Among them, uptake reductions in 
the left frontal lobe (acute 42.3   8   33.0, chronic 23.7   8   19.9; p = 0.035) were significantly se-
verer and those in the left temporal lobe tended to be lager in the acute-onset patients (acute 
39.5   8   53.2, chronic 17.8   8   15.5; p = 0.086) whereas decreases at the left posterior cingulate 
(acute 28.4   8   27.8, chronic 62.6   8   66.3; p = 0.042) were significantly larger in the chronic-
onset patients. A logistic regression revealed that hypoperfusion at the left posterior cingu-
late was a significant determinant of chronicity [odds ratio (OR) = 1.02, p = 0.049, explaining 
11.0% of variance].
   Cognitive  versus  Non-Cognitive . The total uptake decrease in the cognitive group (544.3 
  8   302.8) was larger than that of the non-cognitive group (369.1  8   182.5), and the intergroup 
difference showed a trend toward significance (p = 0.093). Decreases in almost all brain areas 
under consideration were also more profound in the cognitive than non-cognitive group. 
Differences in the left parietal lobes (cognitive 49.2   8   66.4, non-cognitive 19.6   8   21.3) 
reached statistical significance (p = 0.37;   fig. 3  ). Although barely significant on a logistic re-
gression, hypoperfusion at the left parietal (OR = 1.17, p = 0.053), left precuneus (OR = 1.13, 
p = 0.10) and right anterior cingulate (OR = 1.13, p = 0.08) was a possible determinant of cog-
nitive/psychiatric onset.
  Fi g .  1.   Uptake reductions (exten-
sion   !   severity) in comparison 
with age-matched normal con-
trols for each brain area in all 41 
DLB patients. Note that uptake 
reductions are rather ubiquitous 
and not restricted to the occipi-
tal lobes (see text for the techni-
cal comments). Front. = Frontal 
lobes; Temp. = temporal lobes; 
Par. = parietal lobes; Occ. = oc-
cipital lobes; Ant. Cing. = ante-
rior cingulate; Post. Cing. = pos-
terior cingulate; Prec. = precu-
neus. 
  Fi g .   2 .   U p t a k e  r e d u c t i o n s  i n  
acute- and chronic-onset pa-
tients. In acute-onset patients, 
reductions are more frequent in 
the frontal and temporal lobes, 
whereas in chronic-onset pa-
tients reductions are more fre-
quent in the occipital lobes, pos-
terior cingulate and precuneus. 
Abbreviations are the same as in 
figure 1. 245
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  Discussion
    Firstly, this study showed that DLB patients are likely to present a wide range of symp-
toms at the initial stage both in an acute and chronic fashion. Secondly, voxel-based statistical 
SPECT analyses showed that uptake decreases in DLB patients compared with age-matched 
normal controls were rather diffusely distributed, involving both the anterior and posterior 
brain areas and not necessarily restricted to the occipital areas. With regard to onset modal-
ities, left frontal and temporal hypoperfusion appeared associated significantly with acute 
onset, and hypoperfusion in the left posterior cingulate with chronic onset. Thirdly, SPECT 
analyses also suggested that DLB patients presenting cognitive (cognitive/psychiatric) rather 
than non-cognitive (motoric/autonomic) symptoms in the initial stage showed more promi-
nent uptake reduction in almost all brain areas, with an accentuation in the left parietal areas. 
These results may shed light on the association between the wide range of clinical presenta-
tions of DLB and possible pathophysiological variance represented on SPECT. 
  O n s e t   P a t t e r n s
    Symptoms emerged rather rapidly in 21 patients but progressed slowly in the remaining 
20. The consensus criteria state that the central features are ‘progressive’ although the speed 
of exacerbation is not specified. It may be generally understood that symptoms of DLB prog-
ress chronically although faster than PD and AD. Thus, physicians may be confronted with 
diagnostic difficulties when facing DLB patients presenting various combinations of acute 
symptoms within a mean of 2 months, as shown by the acute-onset group. In this situation, 
DLB may be confused with infectious, toxic, traumatic, vascular or acute psychiatric disor-
ders, or even Creutzfeldt-Jakob disease.
    Using the quantitative SPECT analyses, we demonstrated that acute-onset patients 
showed uptake decreases primarily in the anterior part of the brain, specifically the left fron-
tal and temporal lobes, while the chronic-onset patients showed hypoperfusion in the pos-
terior brain areas, specifically the left posterior cingulate regions. Since the total uptake de-
creases were comparable between the acute (472.0   8   252.5) and chronic (486.5   8   335.1) 
groups (p = 0.77; Mann-Whitney U test), it may be deduced that the determinant factor of 
acute-type onset is the distribution of perfusion reduction and not the overall severity.
    Then what constitutes the pathological and functional etiology of acute- and chronic-
onset modalities? Based on the results from the present study, we hypothesized that patho-
  Fi g .   3 .   U p t a k e  r e d u c t i o n s  a r e  
generally more marked in cogni-
t i v e  t h a n  i n  n o n - c o g n i t i v e  p a -
tients. The difference in the left 
parietal lobe reached statistical 
significance. Abbreviations are 
the same as in figure 1. 246
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logical burdens of DLB (both Lewy bodies, LB, and beta amyloid, A    ) accentuated in the 
anterior part of the brain lead to acute onset whereas those rather restricted to the posterior 
part lead to chronic onset. 
    Pathological investigations in DLB demonstrated that LB pathologies dominate in the 
anterior brain areas (amygdala, cingulate, temporal, entorhinal and parahippocampal) and 
are rare in the parietal and occipital areas   [25, 26]  . On the other hand, amyloid pathologies 
detected by   11 C-PiB (  11 C-Pittsburgh compound B) PET in an autopsy-confirmed DLB patient 
were distributed in the temporal, insular and orbital frontal cortices as well as posterior cin-
gulate, precuneus and posterior parietal regions   [26]  . With respect to cognitive impairment 
in DLB, both A      and LB pathologies are known to contribute independently   [27]  . When 
taken together, DLB patients with denser LB pathologies may have more frontally distrib-
uted functional impairment depicted on SPECT that associates with acute onset and exacer-
bation. Conversely, chronic-onset DLB patients may have relatively denser A     pathologies in 
the posterior brain areas. As with AD patients, these DLB patients may progress rather slow-
ly compared with LB pathology-dominant patients. However, these assumptions are appar-
ently beyond the scope of this investigation and need a correlative study between SPECT 
patterns and pathology.
    There are some alternative interpretations for these different onset types. Generally, 
frontal lobe-related symptoms (executive dysfunction, incoherence, depression, apathy, ir-
ritability and disinhibition) and temporal lobe-related symptoms (visual hallucinations)  [25]  
may be more alarming to those around the patient and alert them to seek earlier medical 
consultation. In contrast, chronically progressive amnesia that was prevalent in the chronic-
onset group (  table 3  ) may be often taken as granted for the elderly and may allow more time 
before the first medical consultation is sought.
  I n i t i a l   S y m p t o m s
    We showed that onset with cognitive/psychiatric symptoms was associated with more 
extensive and profound hypoperfusion than non-cognitive onset. Given loads of pathologi-
cal changes correlate with hypoperfusion on SPECT   [20]  , we assume that cognitive/psychi-
atric symptoms are likely to be the initial symptom(s) when both LB and A     loads are gener-
ally heavier. Significant uptake decreases in the left parietal lobe in the cognitive group may 
reinforce the previous findings that parietal hypoperfusion, especially on the left, correlates 
with global cognitive impairment in PD   [21]   and lower MMSE scores in PDD   [20]  . In addi-
tion, hypoperfusion at the precuneus is associated with visual cognitive impairment   [11, 19]  . 
The present study further expands this knowledge by showing that generalized hypoperfu-
sion with an accentuation at parietal and precuneus regions, and possibly the right anterior 
cingulate may be associated with onset of cognitive/psychiatric symptoms. Conversely, mo-
tor/autonomic symptoms may initially appear when the pathological changes are more local-
ized and/or milder. In fact, parkinsonism was associated with hypoperfusion relatively con-
fined to the frontal lobes   [7, 17]  .
    Lastly, this study suffers from some limitations. We included only a small number of 
DLB patients (n = 41) because we required brain MRI, SPECT and MIBG myocardial scin-
tigraphy to be performed in all patients in order to compensate for the lack of pathological 
confirmation. We preferred to adopt these rather stringent measures to be able to exclude 
clinically diseases such as AD, progressive supranuclear palsy or multisystem atrophy that 
may initially mimic clinical pictures of DLB. Conversely, the rather strict entry criteria may 
lower the sensitivity of the diagnostic power and cause some patient selection bias.
    The second limitation is associated with the dichotomization of the cardinal initial 
symptoms into cognitive/psychiatric and motoric/autonomic. Ideally, comparisons should 
be made among four groups, namely cognitive, psychiatric, motoric and autonomic groups, 247
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or even eight groups when the onset patterns are also considered. However, cognitive and 
psychiatric or motoric and autonomic symptoms often coexisted, and their borders are often 
vague. Furthermore, the total number of patients being small, too fine a classification would 
have made statistical comparisons difficult.
    The third difficulty may be associated with the definition of onset types. The cutoff of 
6 months was arbitrarily determined on the factual observation that most acute-onset pa-
tients develop all symptoms within 6 months, mostly within a few days to weeks, and in most 
chronic-onset patients it took   1  6 months, mostly 1–3 years, for symptoms to develop.
    In spite of all these shortcomings, this study provided more insights into the onset pat-
terns, initial symptoms and related possible pathophysiology in DLB patients.
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